Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | GSK | REGN | ||
| Company | Celgene Corp | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 108.01 | 51.96 | 623.16 | ||
| High | 108.59 | 52.48 | 633.57 | ||
| Low | 107.27 | 51.72 | 619.78 | ||
| Latest | 108.24 | 51.89 | 620.14 | ||
| Change | +0.11 | +0.80 | -3.29 | ||
| % Change | +0.10% | +1.57% | -0.53% | ||
| Volume | 191,230,496 | 3,512,156 | 696,589 | ||
| 20-Day Average Volume | 16,188,930 | 3,988,992 | 1,179,289 | ||
| Previous Close | 108.13 | 51.09 | 623.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 51.23 | 614.87 | ||
| 20-Day Raw Stochastic | 63.25% | 68.03% | 58.05% | ||
| 20-Day Relative Strength | 64.69 | 50.22 | 41.53 | ||
| Weighted Alpha | +46.30 | +28.05 | +5.94 | ||
| Today's Opinion | 100% Buy | 8% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 24% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -0.50% since 06/17/26 | +2.01% since 06/17/26 | ||
| Low | 107.27 on 11/20/19 | 50.43 on 06/18/26 | 594.90 on 06/22/26 | ||
| High | 110.53 on 11/14/19 | 52.44 on 06/25/26 | 633.57 on 06/25/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +0.99% since 05/22/26 | -2.93% since 05/22/26 | ||
| Low | 102.40 on 10/21/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 53.45 on 06/12/26 | 648.49 on 05/26/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -5.14% since 03/25/26 | -17.26% since 03/25/26 | ||
| Low | 93.41 on 08/23/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 59.57 on 04/14/26 | 781.21 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +5.98% since 12/24/25 | -20.87% since 12/24/25 | ||
| Low | 89.08 on 07/23/19 | 47.62 on 01/20/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 61.69 on 02/18/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 103,463,792 | 65,909,020 | ||
| Shares Outstanding, K | 711,714 | 2,025,128 | 105,720 | ||
| Annual Sales | 15,281,000,000 | 43,077,970,000 | 14,342,900,000 | ||
| Annual Net Income | 4,046,000,000 | 7,537,690,000 | 4,504,900,000 | ||
| Last Quarter Sales | 4,520,000,000 | 10,280,080,000 | 3,605,400,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 2,340,610,000 | 727,200,000 | ||
| 60-Month Beta | 1.41 | 0.36 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 1.24 on 04/29/26 | 9.47 on 04/29/26 | ||
| Earnings Date | 01/30/20 | 07/29/26 | 08/07/26 | ||
| Most Recent Dividend | N/A | 0.454 on 05/15/26 | 0.940 on 05/20/26 | ||
| Next Ex-Dividends Date | N/A | 05/15/26 | 05/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 11.25 | 16.64 | ||